Market Closed -
Other stock markets
|
Pre-market 12:40:38 | |||
70.81 USD | +1.21% |
|
71 | +0.26% |
12:26pm | Goldman Sachs Adjusts Price Target on Gilead Sciences to $71 From $73, Maintains Neutral Rating | MT |
07-11 | Morgan Stanley Adjusts Price Target on Gilead Sciences to $74 From $78 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.59% | 88.22B | |
+63.05% | 856B | |
+39.44% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+5.19% | 234B | |
+16.26% | 226B | |
+14.63% | 177B | |
+1.08% | 165B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Goldman Sachs Adjusts Price Target on Gilead Sciences to $71 From $73, Maintains Neutral Rating